These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4548512)

  • 1. Survival of human peripheral blood lymphocytes in short-time PHA cultures in cancer patients and healthy controls.
    Babusikovå O; Medzihradsky J
    Neoplasma; 1974; 21(6):655-8. PubMed ID: 4548512
    [No Abstract]   [Full Text] [Related]  

  • 2. Change in the proportion of T and B lymphocytes in human malignant neoplasia in relation to the clinical stage.
    Babusíková O; L' Novotná ; Korec S; Schneková K; Turková D; Havránková M; Plentová K
    Neoplasma; 1975; 22(4):413-21. PubMed ID: 1081657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local cellular expressions of the control of neoplasms by the organism. Study conducted on preneoplastic lesions and of human tumors of various organs (skin, uterus, lung, stomach, breast)].
    Maltoni C; Babini G
    Cancro; 1968; 21(6):585-600. PubMed ID: 5761147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 5. T and B lymphocytes in malignant melanoma patients.
    Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
    Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
    Grinevich IuA; Drannik GN; Nikol'skiĭ IS; Kalinina NA; Litvishchenko EI
    Vopr Onkol; 1984; 30(12):23-7. PubMed ID: 6240157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of immune complexes in the blood of oncological patients].
    Grinevich IuA; Alferov AN
    Lab Delo; 1981; (8):493-6. PubMed ID: 6168812
    [No Abstract]   [Full Text] [Related]  

  • 10. Preferential enhancement of human T cell survival "in vitro" using subthreshold concentration of phytohemagglutinin.
    Leser PG; Naspitz K; Tatani T
    Rev Bras Pesqui Med Biol; 1977; 10(5):289-91. PubMed ID: 304235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
    Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
    Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B lymphocytes in cancer patients.
    Sengupta U; Dutta TK; Gupta BD; Aikat BK
    Indian J Cancer; 1978 Jun; 15(2):6-9. PubMed ID: 312245
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte response to PHA in breast cancer: correlation of predicted prognosis to response to different PHA concentrations.
    Whitehead RH; Bolton PM; Newcombe RG; James SL; Hughes LE
    Clin Oncol; 1975 Sep; 1(3):191-200. PubMed ID: 1082405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Specific features of endogenous autorosette formation in the peripheral blood of cancer patients].
    Korichkina LN; Lavrinenko LV; Vinogradova TS; Salova NV; Gusakova GV
    Vopr Onkol; 2008; 54(1):62-4. PubMed ID: 18416060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of regulatory T cells in the peripheral blood of cancer patients.
    Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
    Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of whole-body artificial hyperthermia on the immunity function in cancer patients].
    Dzhaginian AI; Balliuzek FV
    Vopr Onkol; 1984; 30(5):39-43. PubMed ID: 6730415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.